UBS Upgrades Ionis Pharmaceuticals (IONS) to Neutral

May 7, 2021 4:11 AM
UBS analyst Esther Rajavelu upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Sell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Upgrades